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Bacterial effector proteinsAbstract Recently, two mammalian proteins with functional Glu-Pro-Ile-Tyr-Ala (EPIYA) or a
similar sequence (EPIYA-like motif) have been identiﬁed. Pragmin contains a single EPIYA motif
and p140Cap contains two EPIYA-like motifs (EPLYA/EGLYA). Searching the human proteome
using the NCBI BLAST software revealed that EPIYA-like motifs such as EPLYA, ESIYE,
EDLYA, ESIYA, EHIYD, EPIYD, ENIYE, EPVYA, EVVYA, and TPLYA (which are present
in bacterial effectors and have roles in virulence) are present in mammalian proteins. Moreover,
several of bacterial EPIYA-like motifs were duplicated in mammalian proteins. Since, only ﬁve
mammalian proteins contain EPIYA motif, and there are no mammalian proteins with more than
one copy of the EPIYA motif. We also showed that the most of EPIYA (or -like) motifs in mam-
malian proteins are predicted to be naturally ordered. Moreover, few mammalian proteins contain-
ing EPIYA (or -like) motif were tyrosine phosphorylated. On the other hand, most of the
mammalian proteins contain ‘‘unfunctional EPIYA (or -like) motifs’’. Notably, regulation of Src
family kinases’ (SFKs) activity (including up and down regulation) originally is mediated by their
own EPIYA like motifs (EPIYI and EPQYQ) and thereby, it seems that EPIYA (or -like) motifs are
‘‘potential regulators of SFKs’’. Therefore, it can explain why EPIYA (or -like) motifs are restricted
sites with low copy number in most mammalian proteins whereas in bacterial effector proteins, they
can be universal sites with repetitive copies. In this study, we identiﬁed new mammalian proteins
which contain functional EPIYA (or -like) motifs and thereby, their possible roles in cell signal
transduction pathways. In this respect, functional experiments will be necessary to conﬁrm our
ﬁndings.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The presence of the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif or a
sequence closely related to the EPIYA motif (EPIYA-like
motif) in effector proteins that play roles in the virulence of
pathogenic bacteria was analyzed (Table 1). Bacterial effector
proteins enter mammalian cells through type III or type IV
secretion systems (T3SS or T4SS), and these effector proteins
are phosphorylated at tyrosine residues located at the EPIYA
(or -like) motif by host kinases, which triggers an interaction
Table 1 List of bacterial effector proteins which can be tyrosine phosphorylated by host kinases at EPIYA (or -like) motif.
Pathogen Eﬀector
protein
EPIYA (or -like) motifs Tyrosine kinases
involved
References
H. pylori CagA EPIYA SFKs, Abl Poppe et al. (2007), Tammer et al. (2007),
Mueller et al. (2012)
A. phagocytophilum AnkA ESIYE, EDLYA, ESIYA, EPIYA SFKs, Abl Ijdo et al. (2007)
C. trachomatis Tarp ENIYE SFKs, Abl, Syk Mehlitz et al. (2008)
H. ducreyi LspA EPIYG, EPVYA SFKs Deng et al. (2008)
B. henselae Bep EPLYA, EVVYA, TPLYA, EPLYA SFKs (?) Schulein et al. (2005)
EPEC; C. rodentium Tir VNPYA, EHIYD; EPIYD Fyn, Abl Campellone and Leong (2005),
Phillips et al. (2004), Swimm et al. (2004),
Deng et al. (2003)
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lates the function of host cells for more effective infection
and improved colonization (Selbach et al., 2009; Backert
et al., 2010; Hayashi et al., 2013).
Among mammalian proteins, it was demonstrated that
Pragmin EPIYA motif undergoes tyrosine phosphorylation
at the EPIYA motif by Src family kinases (SFKs) or in
response to EGF stimulation. Tyrosine phosphorylation at
the EPIYA allows Pragmin to interact with the SH2 domain
of Csk, and thereby sequesters Csk in the cytoplasm.
Sequestration of Csk by Pragmin has a positive feedback
on SFK activity (Safari et al., 2011). In another study,
Repetto et al. (2013) showed that N-terminal of p140Cap
(also known as SRC kinase signaling inhibitor 1) contains
two EPIYA-like motifs (EPLYA and EGLYA) which can
be tyrosine phosphorylated at EPLYA and EGLYA by c-
Abl or in response to integrin-mediated adhesion and EGF
stimulation. Upon tyrosine phosphorylation, p140Cap
EPLYA and EGLYA sequences serve as binding sites forA
B
Figure 1 (A) List of human EPIYA containing proteins. By using Ph
found which are shown in red boxes. The logo plot was also genera
mammalian proteins which contain functional EPIYA motif calculated
information.)the SH2 domain of Csk (Repetto et al., 2013; Sharma
et al., 2013). Moreover, C-terminal of p140Cap contains a
proline rich sequence which interacts with Src SH3 domain
and thereby, facilitates inhibition of SFK activity by Csk
(Di Stefano et al., 2007). Taken together, it has recently
been proposed that the mammalian EPIYA (or -like) motif
might have been exploited by pathogenic bacteria (Safari
et al., 2011).
In this study, we identiﬁed all of bacterial EPIYA-like
motifs in mammalian proteins and by using PhosphoSite, we
explored the functional EPIYA (or -like) motifs in mammalian
proteins. Furthermore, by using RONN tool, we did structure
disorder prediction for mammalian proteins containing EPI-
YA (or -like) motifs. Our results provided new information
about differences between mammalian and bacterial EPIYA
(or -like) motifs. Furthermore, our ﬁndings may give insights
into the role of EPIYA (or -like) motif in new mammalian pro-
teins to regulate SFK activity as the target of EPIYA (or -like)
motifs.osphoSite, the functional EPIYA motifs containing proteins were
ted with the WebLogo tool. (B) Structure disorder prediction of
with the RONN tool. (See above-mentioned references for further
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Figure 2 (A and B) List of human EPIYA-like motifs (EGLYA and EPLYA) containing proteins. Functional EGLYA and EPLYA
motifs in mammalian proteins are shown in red boxes. Alignment of sequence surrounding EGLYA and EPLYA motifs is displayed and
structure disorder prediction of mammalian proteins which contain functional EPIYA-like motifs (EPLYA or EGLYA) is shown. (See
above-mentioned references for further information.)
278 F. Safari2. Material and methods
NCBI (National Center for Biotechnology Information, U.S.
National Library of Medicine, www.ncbi.nlm.nih.gov) was
used to obtain sequences of mammalian EPIYA (or -like)
motif containing proteins.
PhosphoSitePlus was used for the detection of tyrosine
phosphorylation at EPIYA (or -like) containing proteins
(http://www.phosphosite.org) (Hornbeck et al., 2012).
RONN tool was used for prediction of structure disorder of
EPIYA (or -like) motif in mammalian proteins, (www.stru-
bi.ox.ac.uk/RONN) (Yang et al., 2009).WebLogo 3 was used to align and display protein sequences
(http://code.google.com/p/weblogo/) (Crooks et al., 2004).
3. Results
3.1. Tyrosine phosphorylation and structure disorder prediction
of EPIYA segments in mammalian proteins
It was assumed that ﬂexible feature of bacterial EPIYA (or -
like) segments allows them to interact with huge number of
SH2-domain containing proteins in a tyrosine-phosphoryla-
tion-dependent manner (Hayashi et al., 2012, 2013). Moreover,
Table 2 List of Human EPIYA-like motif containing proteins (EPIYA-like motifs which are present in bacterial effectors and have
roles in virulence). Mammalian proteins with functional EPIYA-like motifs are shown in red boxes.
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motif (Safari et al., 2011). Therefore, the question was whether
EPIYA segments in mammalian proteins show order feature
which is different from ﬂexible feature of bacterial EPIYA
segment and thereby, by using Phosphosite, we ﬁrst explored
tyrosine phosphorylation of EPIYA motif mammalian
containing proteins. Our results showed that two out ﬁve
mammalian proteins containing EPIYA motif were tyrosine
phosphorylated (Fig. 1A). We then used RONN tool to
predict disorder structure of EPIYA segments of mammalian
proteins which were tyrosine phosphorylated. Our results
indicated that Pragmin EPIYA segment revealed ﬂexible fea-
ture which is similar to that of bacterial EPIYA segment
(Fig. 1B). This result was not unexpected because of similar
sequences distal between Pragmin EPIYA motif (EPIYAE-
SAKR) and CagA-B EPIYA motif (EPIYAQVAKK).
3.2. Identiﬁcation of functional EPIYA-like motifs in
mammalian proteins
p140Cap contains two EPIYA-like motifs (EPLYA and
EGLYA) (Repetto et al., 2013). This result indicates that EPI-
YA-like motif in mammalian proteins has a function similar to
that of EPIYA motif. Moreover, it raises a possibility that the
EPIYA-like motifs (which are present in bacterial effectors andhave roles in virulence) are present in mammalian proteins. To
examine this possibility, ﬁrst, we searched EPIYA-like motifs
(EPLYA or EGLYA) in the human proteome by using NCBI
BLAST software and our results showed that 11 mammalian
proteins contain single EGLYA sequences and two mamma-
lian proteins contain single EPLYA sequences (Fig 2A and
B). However, only two out 14 mammalian proteins containing
EGLYA or EPLYA were tyrosine phosphorylated. Disorder
structure prediction for EPIYA-like segments of two mamma-
lian proteins indicated that p140Cap has rigid feature and the
other protein (Partitioning defective 3 homolog B) showed
ﬂexible feature. Interestingly, sequences distal Partitioning
defective 3 homolog B EGLYA (EGLYAKVNKP) showed
homology with CagA-A EPIYA motif (EPIYAKVNKK)
(Fig. 2A). In this respect, it was shown that EPIYA like motifs
such as ESIYE, EDLYA, ESIYA, EPIYG, VNPYA, EHIYD,
EPIYD, ENIYE, EPVYA, EVVYA and TPLYA, which have
roles in virulence, can be found in bacterial effector proteins
(Selbach et al., 2009; Backert et al., 2010; Hayashi et al.,
2013). We then investigated whether mammalian proteins con-
tain such EPIYA-like motifs. Our results revealed that except
EPIYG and VNPYA, all bacterial EPIYA-like motifs are
present in mammalian proteins (Table 2), and bacterial
EPIYA-like motif (ENIYE) is more common in mammalian
proteins (Table 3). Among mammalian proteins containing
Table 3 Frequencies of the 12 types of bacterial EPIYA-like
motifs in mammalian proteins. *EGLYA sequence is present in
p140Cap (i.e. EGLYA sequence is not present in bacterial
effector proteins which were discussed in this study).
EPIYA-like motif Frequencies
EPLYA 3
ESIYE 3
EDLYA 5
ESIYA 1
EPIYG 0
VNPYA 0
EHIYD 3
EPIYD 2
ENIYE 8
EPVYA 3
EVVYA 1
TPLYA 5
*EGLYA 11
Total 45
Figure 3 Structure disorder prediction of mammalian p
280 F. Safaribacterial EPIYA (or -like) motifs, only seven proteins were
tyrosine phosphorylated. Disorder structure prediction of
seven mammalian proteins containing bacterial EPIYA-like
motifs showed that four proteins are naturally disordered
(Fig. 3).
3.3. Identiﬁcation of mammalian proteins with duplication of
bacterial EPIYA like motifs
It was assumed that the presence of numerous EPIYA (or -
like) copies in bacterial effector proteins with disordered
features allowed them to interact with several SH2-domain-
containing proteins (Hayashi et al., 2012, 2013). The presence
of two EPIYA like motifs (EPLYA and EGLYA) in p140Cap,
raises a possibility that the mammalian proteins may contain
duplication of EPIYA like motifs and we wished to know
the structure disorder prediction of them. So, we explored
human proteome to ﬁnd all proteins with duplication of bacte-
rial EPIYA-like motifs and we found that several bacterial
EPIYA-like motifs are duplicated in mammalian proteins
(eight proteins) and only two of them were tyrosine phosphor-
ylated (Fig. 4A). However, none of them are predicted to be
disordered in EPIYA-like segments (Fig. 4B).roteins which contain functional EPIYA-like motifs.
AB
Figure 4 (A) List of human proteins which contain double EPIYA-like motif. (B) Structure disorder prediction of mammalian proteins
with double EPIYA like motifs. (See above-mentioned references for further information.)
A
B
Figure 5 (A and B) The presence of two EPIYA-like motifs (EPIYI and EPQYQ) in SFK members. (See above-mentioned references for
further information.)
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282 F. Safari3.4. The presence of functional EPIYA-like motifs in SFK
members and regulation of SFK activity via their own EPIYA-
like motifs
In the current study, we focused on the functional EPIYA (or -
like) motifs (that have virulence roles in bacterial effector
proteins) in mammalian proteins. However, it was shown that
p140Cap contains EGLYA sequence that is not present in
bacterial effector proteins. Therefore, it suggests that the
non-bacterial EPIYA-like motifs are also present in mamma-
lian proteins. In this respect, we found that members of Src
family kinases contain duplication of functional EPIYA-like
motifs. It was shown that N-terminal SH2 domain of SHP-1
interacts with phosphorylated tyrosine residue (or-Y338)
which is located at EPIYA-like motif,’’ EPIYI’’, of c-Src and
thereby, up regulates Src activity in platelets and lymphocytes
(Smart et al., 1981; Somani et al., 1997). Moreover, Y338 is
conserved in all SFK members, although, the function of this
tyrosine residue in the other SFK members is still unknown
(Fig. 5A). Of note, the activity of SFKs was down regulated
by Csk via EPIYA-like motif ‘‘EPQYQ’’ (Okada et al.,
1988a,b; Okada et al., 1991). On the other hand, Csk is the
responsible kinase which phosphorylates tyrosine residue (or-
Y530 in c-Src) that is located at EPIYA-like motif ‘‘EPQYQ’’
(Fig. 5B). These results suggest that EPIYA (or -like) motifs
can originally play regulatory roles for SFK members.4. Conclusion
The sequence EPxYAxV (where x is any amino acid) is signif-
icantly underrepresented in mammalian proteomes (Selbach
et al., 2009). However, the number of mammalian proteins
containing EPIYA-like motifs is not as low as it was proposed
before (Xu et al., 2010; this paper). This difference may be due
to explanation of ‘‘EPIYA-like motif’’. In the current study,
we identiﬁed 50 mammalian proteins which contain bacterial
EPIYA (or -like) motifs. Our results showed that most of
mammalian proteins containing EPIYA (or -like) motifs were
not tyrosine phosphorylated at EPIYA (or -like) motifs and
thereby, they are ‘‘unfunctional EPIYA (or -like) motifs’’.
Since, bacterial effector proteins containing same EPIYA (or
-like) motifs were tyrosine phosphorylated. In this regard, we
found that out of 11 functional EPIYA (or -like) motifs in
mammalian proteins, six proteins were predicted to be
naturally unfolded. Moreover, out of 39 proteins containing
unfunctional EPIYA (or -like) motif, 32 proteins were
predicted to be ordered at EPIYA (or -like) segments. There-
fore, in mammalian proteins containing EPIYA (or -like)
motif, tyrosine phosphorylation at unfolded EPIYA (or -like)
segments is more frequent than ordered EPIYA (or -like) seg-
ments. Although, bacterial effector proteins were continuously
tyrosine phosphorylated by host tyrosine kinases which seems
to be due to unfolded nature of bacterial EPIYA (or -like)
motifs. Our results also raise a possibility that EPIYA (or -
like) motifs can be potential regulators of SFK members in
the cell machinery. On the other hand, SFK activity can be
directly regulated via their own EPIYA-like motifs (EPIYI
and EPQYQ) or via indirect feedback by functional EPIYA
(or -like) motifs containing proteins (including mammalian
proteins and pathogenic effector proteins). During long-term
co-evolution with hosts, pathogenic bacteria enable to employhost key regulators such as EPIYA (or -like) to better coloni-
zation. These key regulators were expanded via recombination
(Furuta et al., 2011; Majazki et al., 2013). However, in the
mammalian hosts, such key regulators are mostly unfunctional
with low copy number. Furthermore, it seems that intramolec-
ular interactions in mammalian proteins containing EPIYA
(or -like) allowed the EPIYA (or -like) segments to be as unac-
cessed sites. Notably, SFKs have pleiotropic functions in the
regulation of fundamental cellular processes. SFKs are highly
conserved across the animal kingdom, and regulation of SFKs
is a prerequisite for evolution of multicellular animals (Segawa
et al., 2006; Okada, 2012). Our ﬁndings showed that via tyro-
sine phosphorylation at EPIYA (or -like) motifs, mammalian
proteins can interact with Csk (Safari et al., 2011; Repetto
et al., 2013) and SHP-1 (Somani et al., 1997). In this study, sev-
eral mammalian proteins with functional EPIYA (or -like)
motifs were identiﬁed for which interacting partner(s) are still
unknown. So, it would be interesting to gain a better under-
standing of SFK activity via EPIYA (or -like) motifs. More-
over, elucidation of the structure of mammalian proteins
containing EPIYA (or -like) motif proteins will provide more
information on the speciﬁcity of mammalian EPIYA (or -like)
segments. It is known that SFKs are activated in some human
cancers, including colon and breast cancer (Summy and
Gallick, 2003). In this respect, the role of Pragmin EPIYA
motif in activation of SFKs should be explored. Notably,
SFKs are candidates for the treatment of human cancers
(Kopetz et al., 2007; Hollande et al., 2010). Therefore, the
speciﬁcity of EPIYA (or -like) segments to regulation of
SFK activity should be further explored.
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